Tirzepatide (LY3298176) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for type 2 diabetes research. Our facility offers high-quality tirzepatide at competitive prices with flexible customization options.
This innovative peptide demonstrates superior efficacy in glucose control and weight loss compared to selective GLP-1 receptor agonists. The dual agonist mechanism provides enhanced therapeutic potential for metabolic disorder research.
We provide tirzepatide in various concentrations (5mg, 10mg, 15mg, 20mg, 30mg, 50mg) to meet different research requirements. Custom formulations and labeling options are available for bulk orders.
All batches undergo rigorous quality control testing to ensure 99%+ purity. Our manufacturing process complies with strict pharmaceutical standards to deliver consistent, high-performance research materials.
For researchers seeking reliable tirzepatide prices without compromising quality, our facility offers cost-effective solutions with flexible order quantities. We maintain transparent pricing structures for academic and institutional research projects.